DeepPath™–LYDIA is a CE-Marked decision support system for outlining metastases on 20X-40X WSIs of H&E stained LN sections from adult patients with melanoma, breast (female only), colon and lung cancer (additional types TBA).
A WSI is processed within 10 minutes with Sensitivity>99% and a FPR of 9 False Positive segments per LN.
System utilisation accelerates the diagnostic process by up to 5 times per WSI. A much greater efficiency increase is expected because the maximum tumour diameter for all WSIs of a single case is visible at once.
The system is fully integrated in Sectra and the user doesn’t need to navigate to different software to view results, which greatly facilitates workflow efficiency.
When using this diagnostic aid, medical professionals are fully liable for the clinical report.
Application can be launched from Sectra's pathology image window: Yes
Results will be shown in Sectra's pathology image window: Yes
Ask your Sectra representative which version of the Sectra PACS is compatible with the highlighted integration standards.
Contact usAre you interested in learning more? Please do not hesitate to get in touch with us at Sectra.
The application content is provided by the respective AI vendors.
